These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 16374840

  • 21. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells.
    Lovekamp-Swan T, Chaffin CL.
    Mol Cell Endocrinol; 2005 Apr 15; 233(1-2):15-24. PubMed ID: 15767042
    [Abstract] [Full Text] [Related]

  • 22. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells.
    Yan KH, Yao CJ, Chang HY, Lai GM, Cheng AL, Chuang SE.
    Mol Carcinog; 2010 Mar 15; 49(3):235-46. PubMed ID: 19908241
    [Abstract] [Full Text] [Related]

  • 23. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
    Nagahara T, Okano J, Murawaki Y.
    Oncol Rep; 2007 Nov 15; 18(5):1281-90. PubMed ID: 17914586
    [Abstract] [Full Text] [Related]

  • 24. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W, Takahashi N, Nagamine M, Sawamukai M, Tanno S, Kohgo Y, Okumura T.
    Int J Cancer; 2004 Jan 01; 108(1):41-6. PubMed ID: 14618613
    [Abstract] [Full Text] [Related]

  • 25. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S.
    Mol Pharmacol; 2008 Oct 01; 74(4):952-63. PubMed ID: 18599600
    [Abstract] [Full Text] [Related]

  • 26. Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines.
    Turturro F, Friday E, Fowler R, Surie D, Welbourne T.
    Clin Cancer Res; 2004 Oct 15; 10(20):7022-30. PubMed ID: 15501982
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.
    Yu HN, Noh EM, Lee YR, Roh SG, Song EK, Han MK, Lee YC, Shim IK, Lee SJ, Jung SH, Kim JS, Youn HJ.
    Biochem Biophys Res Commun; 2008 Dec 05; 377(1):242-7. PubMed ID: 18835379
    [Abstract] [Full Text] [Related]

  • 29. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
    Komatsu Y, Ito I, Wayama M, Fujimura A, Akaogi K, Machida H, Nakajima Y, Kuroda T, Ohmori K, Murayama A, Kimura K, Yanagisawa J.
    Biochem Biophys Res Commun; 2008 May 23; 370(1):145-8. PubMed ID: 18355447
    [Abstract] [Full Text] [Related]

  • 30. Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Hseu YC, Chen SC, Chen HC, Liao JW, Yang HL.
    Food Chem Toxicol; 2008 Aug 23; 46(8):2680-8. PubMed ID: 18550246
    [Abstract] [Full Text] [Related]

  • 31. Silibinin efficacy against human hepatocellular carcinoma.
    Varghese L, Agarwal C, Tyagi A, Singh RP, Agarwal R.
    Clin Cancer Res; 2005 Dec 01; 11(23):8441-8. PubMed ID: 16322307
    [Abstract] [Full Text] [Related]

  • 32. Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
    Schaefer KL, Wada K, Takahashi H, Matsuhashi N, Ohnishi S, Wolfe MM, Turner JR, Nakajima A, Borkan SC, Saubermann LJ.
    Cancer Res; 2005 Mar 15; 65(6):2251-9. PubMed ID: 15781638
    [Abstract] [Full Text] [Related]

  • 33. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
    Cheng Y, Ping J, Xu LM.
    Chin Med J (Engl); 2007 May 05; 120(9):794-801. PubMed ID: 17531121
    [Abstract] [Full Text] [Related]

  • 34. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
    Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park YC, Suh H, Kim GY, Choi YH, Kim ND.
    Cancer Lett; 2008 Oct 18; 270(1):77-86. PubMed ID: 18554781
    [Abstract] [Full Text] [Related]

  • 35. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T, Fujiwara Y, Hamaguchi M, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Higuchi K, Arakawa T.
    Oncol Rep; 2005 Apr 18; 13(4):601-6. PubMed ID: 15756430
    [Abstract] [Full Text] [Related]

  • 36. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C, Demetris AJ, Michalopoulos GK, Zhan Q, Shelhamer JH, Wu T.
    Hepatology; 2003 Jul 18; 38(1):167-77. PubMed ID: 12829999
    [Abstract] [Full Text] [Related]

  • 37. Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists.
    Sato H, Ishihara S, Kawashima K, Moriyama N, Suetsugu H, Kazumori H, Okuyama T, Rumi MA, Fukuda R, Nagasue N, Kinoshita Y.
    Br J Cancer; 2000 Nov 18; 83(10):1394-400. PubMed ID: 11044367
    [Abstract] [Full Text] [Related]

  • 38. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
    Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H.
    Gastroenterology; 2003 Feb 18; 124(2):361-7. PubMed ID: 12557142
    [Abstract] [Full Text] [Related]

  • 39. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
    Liu TZ, Chen CY, Yiin SJ, Chen CH, Cheng JT, Shih MK, Wang YS, Chern CL.
    Food Chem Toxicol; 2006 Feb 18; 44(2):227-35. PubMed ID: 16112786
    [Abstract] [Full Text] [Related]

  • 40. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
    Nakamoto N, Higuchi H, Kanamori H, Kurita S, Tada S, Takaishi H, Toda K, Yamada T, Kumagai N, Saito H, Hibi T.
    Int J Oncol; 2006 Sep 18; 29(3):625-35. PubMed ID: 16865278
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.